doi: 10.3389/fmed.2026.1810363 Received 13 February 2026 Revised 18 March 2026 Accepted 23 March 2026 Published 04 May 2026 Volume 13 - 2026 Edited by Ramona Cioboata, University of Medicine and Pharmacy of Craiova, Romania Reviewed by Robert Steven Wallis, The Aurum Institute, South Africa Giuseppe Castaldo, University of Naples Federico II, Italy Updates Copyright 2026 Barne, Shevade, Bhattacharyya, Christopher, Nair, Abhyankar, Halder, Vora, Khanna, Swarnakar, Chhajed, Santhalingam, Nair and Salvi
It is equally important to inform your healthcare provider of any other medications that you are taking before starting this medication
The peptide can handle this without significant potency loss
Managing Food Aversions and Low Appetite Days Food aversions during Retatrutide treatment are normal and well documented